Mid Hudson Oncology Physicians Pllc is categorized under Oncologists in Poughkeepsie, NY and active since 2008.
Mid Hudson Oncology Physicians Pllc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel Z Aronzon at the company’s single location by writing to 45 Reade Place, Poughkeepsie, New York NY 12601 or by phoning (845) 483-6217. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mid Hudson Oncology Physicians Pllc |
| Contact Person: | Daniel Z Aronzon |
| Address: | 45 Reade Place, Poughkeepsie, New York 12601 |
| Phone Number: | (845) 483-6217 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Mid Hudson Oncology Physicians Pllc was started in 2008 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Z Aronzon for inquiries that concern Mid Hudson Oncology Physicians Pllc by calling the company number (845) 483-6217, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid Hudson Oncology Physicians Pllc can be found at the coordinates 41.69438,-73.935027 as well as the street address 45 Reade Place in Poughkeepsie, New York 12601.
For its online presence, you may visit Mid Hudson Oncology Physicians Pllc’s website at and engage with its social media outlets through on Twitter and on Facebook.